Glaucoma, Angle-Closure: Clinical Trials

5 trials for Glaucoma, Angle-Closure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 unknown. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Terminated 1, Unknown 1
Phase 21Completed 1

Follow Glaucoma, Angle-Closure: new trials by email Literature Review of Glaucoma, Angle-Closure trials Research Report on Glaucoma, Angle-Closure

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)
IRX-101, Control - Diabetic Macular Edema, Branch Retinal Vein Occlusion
Phase 3TerminatediRenix Medical, Inc.52021-11-152022-05-24
Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure Glaucoma
Selective Laser Trabeculoplasty, Travoprost/ Timolol/ Azopt/ Brimonidine - Glaucoma
Phase 3UnknownSingapore Eye Research Institute902009-06-012010-05-12
Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?
Triesence, balanced salt solution BSS - Glaucoma
Phase 2 / Phase 3CompletedWills Eye772009-02-012018-07-10
Oculusgen (Ologen) Glaucoma MMC Control in Estonia
ologen (oculusgen) collagen matrix, MMC in Trabeculectomy - Open Angle Glaucoma, Angle Closure Glaucoma
Phase 3CompletedPro Top & Mediking Company Limited202007-07-012017-06-27
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
Travoprost (0.004%), Latanoprost (0.005%) - Glaucoma, Angle-Closure, Ocular Hypertension
Phase 3CompletedAlcon Research2000-01-012008-08-05

Narrower conditions

Glaucoma (3)  ·  Glaucoma, Neovascular (2)  ·  Glaucoma, Open-Angle (2)  ·  Exfoliation Syndrome (1)  ·  Ocular Hypertension (1)  ·  Retinal Vein Occlusion (1)

Broader conditions

Eye Diseases (5)  ·  Ocular Hypertension (4)  ·  Glaucoma (2)  ·  Cardiovascular Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Iris Diseases (1)  ·  Retinal Diseases (1)  ·  Thrombosis (1)  ·  Uveal Diseases (1)  ·  Vascular Diseases (1)  ·  Venous Thrombosis (1)

Interventions

Travoprost (2)  ·  Brimonidine Tartrate (1)  ·  Hanks Balanced Salt Solution (1)  ·  Latanoprost (1)  ·  Timolol (1)  ·  Trabeculectomy (1)  ·  Triamcinolone (1)  ·  brinzolamide (1)

Sponsors

Alcon Research (1)  ·  Pro Top & Mediking Company Limited (1)  ·  Singapore Eye Research Institute (1)  ·  Wills Eye (1)  ·  iRenix Medical, Inc. (1)

Countries

United States (3)  ·  Australia (1)  ·  Estonia (1)  ·  Singapore (1)

Top investigators

Kuldar Kaljurand, MD (1)  ·  Marlene R Moster, MD (1)  ·  Stephen Smith, MD, MS (1)  ·  Tin Aung, FRCOphth (1)

Results publications

PMID 24794283, PMID 25429421, PMID 36912740